This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteers
and you are
between 18 and 65
years old
The phase for this study is not defined.
Show me locations

The purpose

To study the in vivo life span in healthy volunteers of red blood cells generated in vitro from autologous peripheral stem cells. The study will be carried out in 4 phases : - production in vitro of the equivalent of 1 ml of blood, i.e. 5x10e9 enucleated RBC from mononuclear cells isolated from an HSC graft obtained from a healthy volunteers donor. - labeling of these cRBC with 51 Cr - reinjection of the autologous cRBC - follow up of the receivers for a maximum 33 days to measure the half-life span of the injected cells.

Provided treatments

  • Biological: intravenous injection of labeled cRBC
Tris trial is registered with FDA with number: NCT00929266. The sponsor of the trial is Etablissement Français du Sang and it is looking for 1 volunteers for the current phase.
Official trial title:
First Pilot Study Evaluating the Life Span of Autologous Cultured Red Blood Cells (cRBC) Generated From Peripheral Stem Cells in Three Healthy Volunteers - Feasibility Study